2026. Morphologic leukemia-free state after venetoclax-based therapy in acute myeloid leukemia is associated with high relapse despite preserved short-term survival. Mediterranean Journal of Hematology and Infectious Diseases. 18, 1 (Apr. 2026), e2026048. DOI:https://doi.org/10.4084/MJHID.2026.048.